US EditionPublished • loading... • Updated
New Dedicated Clinical Trial Site Launched to Accelerate Epidermolysis Bullosa Research
Summary by Patient Worthy
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
New Dedicated Clinical Trial Site Launched to Accelerate Epidermolysis Bullosa Research
As reported on PM Live, a new clinical trial hub focused on epidermolysis bullosa (EB) has been established at University Medical Center Groningen (UMCG) in the Netherlands through a collaboration with DEBRA Research, marking an important step forward in research into this rare and debilitating group of genetic skin disorders. EB encompasses several inherited conditions […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
